Health
Freiburg researchers receive ERC funding to develop and test immunostimulatory drug candidates – News-Medical.net
With the Proof of Concept funding line, the ERC grants recipients of ERC frontier research funds (Starting, Consolidator, Advanced or Synergy grants) with 150.000…
With the Proof of Concept funding line, the ERC grants recipients of ERC frontier research funds (Starting, Consolidator, Advanced or Synergy grants) with 150.000 Euro to develop promising ideas with commercial or societal potential to the proof of concept stage. With this funding, Olaf Groß and his team in the Metabolism and Inflammation Group at the Institute of Neuropathology of the Medical Center – University of Freiburg will test whether a new class of immune activating drugs they discovered…
-
General16 hours agoMan dies in daylight shooting in Sydney’s north-west
-
Noosa News19 hours agoResident rushed to hospital with multiple burns as house engulfed in flames in Woodridge
-
Noosa News18 hours agoWhy the Brisbane City Hall clock has fallen silent
-
General24 hours agoBrewer stages beer boycott over Kangaroo Island ferry’s ‘ridiculous’ fares